TEC is a philosophy, a high-level strategy that can be incorporated to accelerate any practice in any business environment with a focus on independent practices. After years of watching profits erode and the commoditization of our dispensaries, a novel approach was imperative. Practice differentiation and the premium patient experience are keys to an independent and profitable practice. We did the work for you and aggregated the best-in-class, independent brands in our industry, known simply as TEC—The Eye Consortium. We have taken it even further to create a comprehensive suite of solutions consisting of products and services for your practice to use to increase profitability and remain independent. We aim to ease the pain points that make running a business difficult and time-consuming, allowing you to focus on what matters most—your patients. Creating a community of like-minded business people allows us to curate a specialized group of vendor partners, focus on maintaining your unique environment, and increase your profitability.
| Website | http://eyeconsortium.com |
| Employees | 10 (5 on RocketReach) |
| Founded | 2019 |
| Phone | +1 817-346-7077 |
| Industry | Business Consulting and Services |
| Keywords | Business Acceleration, Strategic Planning, High Level Strategy, Practice Management, Value Creation, Practice Improvement, Growth Strategy, Business Transformation, Profit Optimization, Performance Enhancement, Process Improvement, Sustainable Growth, Competitive Advantage, Revenue Generation, Efficiency Consulting, Operational Efficiency, Scalability Solutions, Market Differentiation, Business Philosophy |
| Competitors | MediSieve, Novartis, ZEISS Group, Actavis plc (now Allergan), Regeneron, Valeant Pharmaceuticals, Alcon, Bausch + Lomb, The Janssen Pharmaceutical Companies of Johnson & Johnson, Abbott +31 more (view full list) |
Looking for a particular TEC Eye Consortium employee's phone or email?
Matthew Alpert is the President and co-founder of TEC Eye Consortium.
5 people are employed at TEC Eye Consortium.